Syntethic vs. natural estrogen in combined oral contraception- effect on insulin sensitivity, inflammation, coagulation and endometrium. A comparison with a progestin-only preparation.

Trial Profile

Syntethic vs. natural estrogen in combined oral contraception- effect on insulin sensitivity, inflammation, coagulation and endometrium. A comparison with a progestin-only preparation.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Estradiol valerate/dienogest (Primary) ; Dienogest; Ethinylestradiol/dienogest
  • Indications Pregnancy
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms SYLVI
  • Most Recent Events

    • 05 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top